GlassScriptPhysician profile
Elias Solomon
NPI 1770624694
$946.82
in general payments reported to CMS, 2019-2025
13 companies · $89.12 in 2025
The $89.12 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $18.55 · 2021: $55.33 · 2022: $135 · 2023: $40.87 · 2024: $134 · 2025: $89.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $165 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $164.87 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $404.29 | 2019 | |
| W. L. Gore & Associates, INC. | $177.58 | 2021-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Actelion Pharmaceuticals US, INC. | $98.99 | 2024 | Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $54.44 | 2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $38.76 | 2023-2024 | Farxiga |
| Conmed Corporation | $31.92 | 2021 | |
| Pfizer INC. | $31.31 | 2019-2020 | |
| Getinge USA Sales, LLC | $29.13 | 2019 | |
| Kestra Medical Technology Services, INC. | $21.33 | 2023 | Assure Wcd |
| Amgen INC. | $17.40 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.66 | 2024 | Lifevest |
| Bridgebio Pharma, INC. | $15.14 | 2025 | Attruby |
| Eisai INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elias Solomon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.